Syros Pharmaceuticals, Inc. SYRS
0.00 USD 0.00 (+0.00%)
Regular-session close
0.11 +0.11 +107,100.00%
After hours · Nov 19, 4:00 PM ET
0.0005 Day range 0.0005
0.0001 52-week range 0.012
- YTD
- -71.43%
- 1 year
- -87.50%
Held by funds
1 US ETFs and mutual funds hold SYRS · largest positions
- STSB 0.01% of fund $616
Ownership
- Institutions 75.6%
- Insiders 0.74%
- Public and other holders 23.7%
Held by insiders 0.74%
Held by institutions 75.59%
Float held by institutions 76.15%
Institutions 80
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10.25% | 2,750,151 | 560.75K | Sep 29, 2024 |
| Siren, L.L.C. | 9.64% | 2,587,372 | 527.57K | Sep 29, 2024 |
| Adage Capital Partners GP L.L.C. | 7.72% | 2,071,914 | 422.46K | Sep 29, 2024 |
| Samsara BioCapital, LLC | 6.66% | 1,786,427 | 364.25K | Sep 29, 2024 |
| Point72 Asset Management, L.P. | 5.49% | 1,471,771 | 300.09K | Sep 29, 2024 |
| Flagship Pioneering Inc. | 4.82% | 1,293,849 | 263.81K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.44% | 654,183 | 133.39K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.96% | 257,635 | 52.53K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.37% | 100,122 | 20.41K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.21% | 56,602 | 11.54K | Oct 30, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.19% | 50,670 | 10.33K | Sep 29, 2024 |
| Fidelity Total Market Index Fund | 0.15% | 39,831 | 8.12K | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AKKARAJU SRINIVAS | Director | Conversion of Exercise of derivative security | Sep 15, 2024 | 9,333 |
| CHEE CONLEY | Chief Executive Officer | Sale | Nov 17, 2024 | 0 |
| FANUCCI MARSHA H | Director | Stock Award(Grant) | Jun 4, 2024 | 16,000 |
| HAAS JASON | Chief Financial Officer | Sale | Nov 17, 2024 | 0 |
| QUIRK GERALD E. | Officer | Sale | Nov 18, 2024 | 0 |
| ROTH DAVID A M.D. | Officer | Sale | Nov 17, 2024 | 0 |
